The DOI matches its Crossref record; 94 of the 96 references it cites were found in a registry or an index.
Long-Term Course of Opioid Addiction
Abstract
Opioid addiction is associated with excess mortality, morbidities, and other adverse conditions. Guided by a life-course framework, we review the literature on the long-term course of opioid addiction in terms of use trajectories, transitions, and turning points, as well as other factors that facilitate recovery from addiction. Most long-term follow-up studies are based on heroin addicts recruited from treatment settings (mostly methadone maintenance treatment), many of whom are referred by the criminal justice system. Cumulative evidence indicates that opioid addiction is a chronic disorder with frequent relapses. Longer treatment retention is associated with a greater likelihood of abstinence, whereas incarceration is negatively related to subsequent abstinence. Over the long term, the mortality rate of opioid addicts (overdose being the most common cause) is about 6 to 20 times greater than that of the general population; among those who remain alive, the prevalence of stable abstinence from opioid use is low (less than 30% after 10-30 years of observation), and many continue to use alcohol and other drugs after ceasing to use opioids. Histories of sexual or physical abuse and comorbid mental disorders are associated with the persistence of opioid use, whereas family and social support, as well as employment, facilitates recovery. Maintaining opioid abstinence for at least five years substantially increases the likelihood of future stable abstinence. Recent advances in pharmacological treatment options (buprenorphine and naltrexone) include depot formulations offering longer duration of medication; their impact on the long-term course of opioid addiction remains to be assessed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is probably the addictive condition where an analysis of cumulative evidence most strikingly supports the notion of a chronic disorder with frequent relapses in a large proportion of people affected [34].”
From Addiction as a brain disease revised: why it still matters, and the need for consilience (2021) · doi:10.1038/s41386-020-00950-y · cites this paper as [34]
Citations
Cites
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 2×
“continuity of care, disease management, and chronic care.(8,98,99) The chronic care model that is used in managing many other chronic illnesses (e.”
BackgroundRelease from prison–a high risk of death for former inmates
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064115 · Cited by 1,684
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
Evidence on the Chronic Care Model in the new millennium
Coleman, K., Austin, B. T., Brach, C., & Wagner, E. H. (2009) · Health Affairs · doi:10.1377/hlthaff.28.1.75 · Cited by 1,606
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,529
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240 · cited 6×
“For example, early indicators of conduct disorder or antisocial personality disorder were evident in 38.7% of a sample of methadone treatment participants at baseline and were associated with slower rates of heroin-use cessation over 30 years.34 Similarly, retrospective reports of pre-service conduct disorder were ass…”
BackgroundInfluentialOpioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856 · cited 1×
“U high heterogeneity across studies.(43) Consistent with this finding, the standardized mortality ratios that are based on the long-term cohort studies included in this review are mostly in the range of 6 to 20 times the rates among the general population.”
Background
Research works printed but not linked: 5
- Schafer, 2000, Sexual and physical abuse during early childhood or adolescence and later drug addiction., Psychother Psychosom Med Psychol, 50, 38
- Darke, 2007, The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence Drug Alcohol R, ev, 26, 49
- Ball, 1969, A test of the maturation hypothesis with respect to opiate addiction., Bull Narc, 21, 9
- Wagner, 1998, Chronic disease management: what will it take to improve care for chronic illness Eff Clin P, ract, 1, 2
- Gunderson, 2008, Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches CNS D, rugs, 22, 99
Cited by
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Gupta, A., Scott, K., & Dukewich, M. (2018) · Pain Medicine · doi:10.1093/pm/pnx109 · Cited by 340
Addiction as a brain disease revised: why it still matters, and the need for consilience
(2021) · doi:10.1038/s41386-020-00950-y · Cited by 290
Chronic pain among patients with opioid use disorder: Results from electronic health records data
Hser, Y.-I., Mooney, L. J., Saxon, A. J., Miotto, K., Bell, D. S., & Huang, D. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.03.006 · Cited by 222
Self-citation
Metadata
- Authors
- Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Hser, Yih-Ing
- Venue
- Harvard Review of Psychiatry
- Published
- 2015-03
- Volume
- 23
- Issue
- 2
- Pages
- 76-89
- ISSN
- 1067-3229 (ISSN-L)
- OpenAlex
- W2315631840
- Cited by
- 299
- References
- 96
- Citations by year
- 2026: 19 · 2025: 27 · 2024: 26 · 2023: 35 · 2022: 36 · 2021: 31 · 2020: 31 · 2019: 24 · 2018: 19 · 2017: 27 · 2016: 13 · 2015: 10
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Harvard Review of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p30da016383-10)
- National Institute on Drug Abuse (P30-DA016383, U10DA013045, U10 DA 13045)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- opioid use disorder, long-term course, heroin addiction, relapse, abstinence, treatment retention, incarceration, drug overdose deaths, comorbid mental disorders, abuse history, social support, employment, buprenorphine, naltrexone, methadone maintenance treatment, life course framework
- MeSH terms
- Analgesics, Opioid, Buprenorphine, Humans, Methadone, Naltrexone, Narcotic Antagonists, Opioid-Related Disorders, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Course of Opioid Addiction. https://app.cochat.ai/papers/10.1097/hrp.0000000000000052
- The paper
- Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-Term Course of Opioid Addiction. Harvard Review of Psychiatry. https://doi.org/10.1097/hrp.0000000000000052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.